BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eliasson L, Clifford S, Mulick A, Jackson C, Vrijens B. How the EMERGE guideline on medication adherence can improve the quality of clinical trials. Br J Clin Pharmacol 2020;86:687-97. [PMID: 32034923 DOI: 10.1111/bcp.14240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Baumgartner SL, Buffkin DE Jr, Rukavina E, Jones J, Weiler E, Carnes TC. A Novel Digital Pill System for Medication Adherence Measurement and Reporting: Usability Validation Study. JMIR Hum Factors 2021;8:e30786. [PMID: 34747709 DOI: 10.2196/30786] [Reference Citation Analysis]
2 Eliasson L, Clifford S, Mulick A, Jackson C, Vrijens B. How the EMERGE guideline on medication adherence can improve the quality of clinical trials. Br J Clin Pharmacol 2020;86:687-97. [PMID: 32034923 DOI: 10.1111/bcp.14240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Edward A, Campbell B, Manase F, Appel LJ. Patient and healthcare provider perspectives on adherence with antihypertensive medications: an exploratory qualitative study in Tanzania. BMC Health Serv Res 2021;21:834. [PMID: 34407820 DOI: 10.1186/s12913-021-06858-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lasala R, Santoleri F, Romagnoli A, Abrate P, Musicco F, Costantini A. Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs. Eur J Hosp Pharm. [DOI: 10.1136/ejhpharm-2021-002998] [Reference Citation Analysis]
5 Tsiogkas SG, Grammatikopoulou MG, Gkiouras K, Zafiriou E, Papadopoulos I, Liaskos C, Dardiotis E, Sakkas LI, Bogdanos DP. Effect of Crocus sativus (Saffron) Intake on Top of Standard Treatment, on Disease Outcomes and Comorbidities in Patients with Rheumatic Diseases: Synthesis without Meta-Analysis (SWiM) and Level of Adherence to the CONSORT Statement for Randomized Controlled Trials Delivering Herbal Medicine Interventions. Nutrients 2021;13:4274. [PMID: 34959826 DOI: 10.3390/nu13124274] [Reference Citation Analysis]
6 Hossain MB, Karim ME. Key considerations for choosing a statistical method to deal with incomplete treatment adherence in pragmatic trials. Pharmaceutical Statistics. [DOI: 10.1002/pst.2258] [Reference Citation Analysis]
7 Tibble H, Flook M, Sheikh A, Tsanas A, Horne R, Vrijens B, De Geest S, Stagg HR. Measuring and reporting treatment adherence: What can we learn by comparing two respiratory conditions? Br J Clin Pharmacol 2021;87:825-36. [PMID: 32639589 DOI: 10.1111/bcp.14458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 van Heuckelum M, van den Ende CHM, van Dulmen S, van den Bemt BJF. Electronic Monitoring Feedback for Improving Medication Adherence and Clinical Outcomes in Early Rheumatoid Arthritis: A Randomized Clinical Trial. Patient Prefer Adherence 2021;15:1107-19. [PMID: 34079231 DOI: 10.2147/PPA.S297170] [Reference Citation Analysis]
9 Dockendorf MF, Hansen BJ, Bateman KP, Moyer M, Shah JK, Shipley LA. Digitally Enabled, Patient-Centric Clinical Trials: Shifting the Drug Development Paradigm. Clin Transl Sci 2021;14:445-59. [PMID: 33048475 DOI: 10.1111/cts.12910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Tsioufis K, Castellano Vázquez JM, Sykara G, Mondello Malvestiti F, van Vugt J. Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy. Cardiol Ther 2021;10:445-64. [PMID: 34586613 DOI: 10.1007/s40119-021-00240-8] [Reference Citation Analysis]